Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
THC Farmaceuticals ( (CBDG) ) has provided an announcement.
On December 31, 2024, the board of THC Farmaceuticals, Inc. approved a change to the company’s fiscal year end from September 30 to December 31 in order to align its reporting cycle with the calendar year and improve the comparability of its financial reporting and planning processes. The company will file the required transition reports for the short fiscal period created by this shift, and the change was implemented without amendments to its Articles of Incorporation or Bylaws, indicating an operational rather than structural adjustment that should streamline reporting for stakeholders and enhance alignment with standard market practice.
More about THC Farmaceuticals
THC Farmaceuticals, Inc. operates in the pharmaceutical sector, with a focus that includes regulated, disclosure-based financial reporting common to public companies in its industry.
Average Trading Volume: 4,727
Technical Sentiment Signal: Hold
Current Market Cap: $828.6K
See more data about CBDG stock on TipRanks’ Stock Analysis page.